Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy
Michael T. Lu(Cancer Research And Biostatistics), Steven Grinspoon(Massachusetts General Hospital), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Júlia Karády(Semmelweis University), Jana Taron(University Medical Center Freiburg), Borek Foldyna(Cancer Research And Biostatistics), Kayla Paradis(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Thomas Mayrhofer(Harvard University), Christopher R. deFilippi, Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Tricia H. Burdo(Temple University), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Sara McCallum(Cancer Research And Biostatistics), Markella V. Zanni(Harvard University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 8
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k